Search for Clinical Trial Results

Sponsored By

Leukemoid Reaction - 6 Studies Found

Status Study
Recruiting Study Name: Study of Blood Samples From Newborns With Down Syndrome
Condition: Leukemia
Date: 2009-08-13
Interventions:
  • Genetic: DNA analysis
  • Genetic: RNA analysi
Withdrawn Study Name: Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder
Condition: Leukemia
Date: 2006-12-11
Interventions:
  • Drug: cytarabine Given subcuta
Completed Study Name: Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder
Condition: Leukemia
Date: 2012-01-13
Interventions:
  • Genetic: RNA analysis
  • Genetic: reverse tra
Completed Study Name: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Acute Leukemias of Ambiguous Lineage
    • Date: 2010-10-29
    Interventions:
    • Drug: Akt inhibitor MK2206 Giv
Completed Study Name: Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
Condition:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • Acute
    Date: 2006-05-02
    Interventions:
    • Radiation: total-body irradiation

Active, not recruiting Study Name: Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
Condition:
  • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
  • Acute Undifferentiated Leukemia
    Date: 2001-04-10
    Interventions:
    • Drug: fludarabine phosphate Gi